Tolerability of Switching to Duloxetine for the Management of Diabetic Nerve Pain

Clinical trial NCT00266643 · COMPLETED

Trial details

NCT number: NCT00266643
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetic Neuropathy, Painful

Start date: 2005-12-01
Enrollment: 205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.